Libor Transition: Five Points Firms Still Need to Consider

Six years ago the now Governor of the Bank of England, Andrew Bailey announced that “the survival of Libor [London Interbank Offer Rate] could not and would not be guaranteed past end 2021”.

In that time the markets have transitioned from what was described as “the world’s most important number” by the British Bankers Association linked to more than $300 trillion worth of contracts globally, to a range of overnight risk-free rates (RFRs) that can be used across all assets, including loans, bonds and derivatives.

While the transition has so far proved a success, there are still four synthetic Libor settings remaining; 3-month synthetic sterling Libor and 1-, 3- and 6-month synthetic US dollar Libor. The sterling setting is due to end in March 2024 while the US dollar Libor will follow in September.

As the switch to alternative risk-free rates (ARRs) continues, we provide five points market participants should consider as they prepare for the next round of deadlines;

1. What plans do you have in place to manage liquidity constraints? In part due to macroeconomic conditions and interest rate volatility liquidity in some products - such as SONIA futures and options - has been constrained. Market participants need to understand their Central Bank’s desire to use interest rate changes and open market operations to effect monetary policy. Further, think about the access to a diverse and appropriately liquid set of underlying instruments to manage risk.

2. Are you flexible enough to apply different RFRs across your products?

   It is important in the new multidate environment, that market participants are aware of all of the available rates, their conventions and applicability for specific products.

3. How well are the operational processes, and those of any third parties in your workflow, able to cope with spikes in Repo volumes? SOFR, which references the rate paid by borrowers in overnight repo transactions collateralised by US Treasuries – can be prone to volatility spikes. Market participants need to have systems in place that will limit the impact and ensure stability for clients.

4. How adequate is your RFR stress testing? The new RFR instruments have less than five years of history, but many regulations and capital adequacy regimes require history back to 2007. It is important to have stress tested your RFR portfolio for standard events that occurred over the past 15 years.

5. What is your strategy to deal with new basis risks? There may be differences in the rates used to reference liabilities compared to those used for assets. Firms need to be sure they can manage these legacy exposures.

After years of hard work, the Libor transition is nearly complete, but market participants need to keep their focus to avoid any unexpected complications. Parameta Solutions global subject matter experts prioritise solving market problems and are well placed to help your organisation in the final stages of the journey. https://bankofengland.co.uk

Disclaimer: This communication and all information contained in or attached to it (including, but not limited to market prices/levels and market commentary) (the “Information”) is for informational purposes only, is confidential, may be legally privileged and is the intellectual property of one of the companies of TP ICAP plc group (“TP ICAP”) or third parties. The Information is directed to Eligible Counterparties and Professional Customers only and is not intended for Retail Clients (as each term is defined by the rules of the Financial Conduct Authority or equivalent). The Information is not, and should not be construed as, an offer, bid, recommendation or solicitation in relation to any financial instrument or investment or to participate in any particular trading strategy. The Information is not to be relied upon and is not warranted, including, but not limited, as to completeness, timeliness or accuracy and is subject to change without notice. All representations and warranties are expressly disclaimed. Access to the Information by anyone other than the intended recipient is unauthorised and any disclosure, copying or redistribution is prohibited. The Information and any opinions expressed within it are not to be relied upon as authoritative, or taken in substitution for seeking your own advice or the exercise of your own commercial judgment. The Information has no regard to specific investment objectives and does not comprise investment advice. The Information is not, and should not be construed as, an offer or solicitation to bid, sell or buy any product, investment, security or any other financial instrument. TP ICAP does not promote any of the contents of the Information. TP ICAP does not make any representation or warranty, express or implied, as to the accuracy, completeness or correctness of the Information, which is subject to change without notice. TP ICAP does not accept any responsibility or liability for any direct or indirect loss or damage, howsoever caused, arising from or in connection with the Information. In no circumstances may the products referred to herein be used for any purpose that would cause it to become a benchmark for the purposes of (a) the Regulation (EU) 2016/1011, (b) the UK version of Regulation (EU) 2016/1011 as on shored via the European Union (Withdrawal) Act 2018 (the “UK Benchmarks Regulation”) (c) other applicable benchmark regulation and/or (d) the IOSCO Principles for Financial Benchmarks in each case together with the relevant technical standards, whether by the products referred to being referenced in a financial instrument, financial contract or investment fund or otherwise. (“Prohibited Use”). The terms of this disclaimer are governed by the laws of England and Wales. For further regulatory information and our terms of business, please see www.tpicap.com. ©TPICAP 2023